Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Depreciation & Amortization (CF) (2020 - 2025)

RxSight (RXST) has disclosed Depreciation & Amortization (CF) for 6 consecutive years, with $851000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) rose 65.24% year-over-year to $851000.0, compared with a TTM value of $3.3 million through Dec 2025, down 8.64%, and an annual FY2025 reading of $3.3 million, down 8.64% over the prior year.
  • Depreciation & Amortization (CF) was $851000.0 for Q4 2025 at RxSight, roughly flat from $854000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $1.1 million in Q3 2024 and bottomed at $515000.0 in Q4 2024.
  • Average Depreciation & Amortization (CF) over 5 years is $938900.0, with a median of $972000.0 recorded in 2021.
  • The sharpest move saw Depreciation & Amortization (CF) crashed 51.0% in 2024, then soared 65.24% in 2025.
  • Year by year, Depreciation & Amortization (CF) stood at $1.0 million in 2021, then decreased by 10.44% to $918000.0 in 2022, then rose by 14.49% to $1.1 million in 2023, then plummeted by 51.0% to $515000.0 in 2024, then skyrocketed by 65.24% to $851000.0 in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for RXST at $851000.0 in Q4 2025, $854000.0 in Q3 2025, and $785000.0 in Q2 2025.